| 2,2-Dibromo-3-nitrilopropionamide (DBNPA) |
10222-01-2 |
- |
| 2-Cyanoacetamide |
107-91-5 |
- |
| 4-Hydroxybenzoic acid |
99-96-7 |
- |
| 8-Hydroxyquinoline |
148-24-3 |
|
| Benzalkonium chloride (BKC) 50% |
8001-54-5 |
- |
| Didecyldimethylammonium chloride (DDAC) 80% |
7173-51-5 |
|
| Glutaraldehyde 50% |
111-30-8 |
|
| Glyoxal 40% |
107-22-2 |
|
| Methylchloroisothiazolinone |
26172-55-4 |
- |
| Methylisothiazolinone |
2682-20-4 |
- |
| Oxone™ |
70693-62-8 |
|
| Paraformaldehyde 91% |
30525-89-4 |
|
| Paraformaldehyde 96% |
30525-89-4 |
- |
| Potassium monopersulfate |
37222-66-5 |
|
| Sodium dichloroisocyanurate 56% dihydrate granules |
2893-78-9 |
- |
| Sodium dichloroisocyanurate 60% granules |
2893-78-9 |
|
| Sodium dichloroisocyanurate 60% powder |
2893-78-9 |
- |
| Sodium dichloroisocyanurate 60% tablet |
2893-78-9 |
- |
| Sodium percarbonate coated granules |
15630-89-4 |
|
| Sodium percarbonate tablet |
15630-89-4 |
- |
| Trichloroisocyanuric acid 90% granules |
87-90-1 |
|
| Trichloroisocyanuric acid 90% powder |
87-90-1 |
- |
| Trichloroisocyanuric acid 90% tablet |
87-90-1 |
- |
